Clinical Trials Logo

Filter by:
NCT ID: NCT02484625 Completed - Appetite Clinical Trials

The Effect of Dairy and Non-Dairy Snacks on Food Intake, Subjective Appetite in Children

Start date: November 2011
Phase: N/A
Study type: Interventional

Dairy products have the potential to be healthy snack foods for children and are provided in a variety of food matrices. For instance, milk represents a fluid product, yogurt can be classified as a semi-solid food, and finally, cheese is the example of solid food. This experiment is aimed to examine the effect of dairy products with different food matrices on satiety and food intake in children. Dairy products will be compared with other non-dairy snacks popular among children including cookies and potato chips.

NCT ID: NCT02484443 Completed - Clinical trials for Recurrent Osteosarcoma

Dinutuximab in Combination With Sargramostim in Treating Patients With Recurrent Osteosarcoma

Start date: February 4, 2016
Phase: Phase 2
Study type: Interventional

This phase II trial studies how well dinutuximab works when given with sargramostim in treating patients with osteosarcoma that has come back after treatment (recurrent). Monoclonal antibodies, such as dinutuximab, may find tumor cells and help kill them. Sargramostim may help the body increase the amount of white blood cells it produces, which help the body fight off infections. Giving dinutuximab with sargramostim may work better and kill more cancer cells.

NCT ID: NCT02484313 Completed - Blood Glucose Clinical Trials

The Effect of Snacks on Glycaemic Regulation in Children

Start date: November 2011
Phase: N/A
Study type: Interventional

Dairy products have a potential to be healthy snack foods for children. The purpose of this project is to investigate the short-term effects of Greek yogurt, a new popular dairy product on the regulation of glucose homeostasis, satiety and energy intake in normal weight and overweight/obese children.

NCT ID: NCT02484170 Completed - Clinical trials for Neuralgia, Postherpetic

Mannitol Cream for Post Herpetic Neuralgia

MannitolPHN
Start date: September 30, 2015
Phase: Phase 1/Phase 2
Study type: Interventional

30% mannitol cream has shown its ability to reduce the activation of the Capsaicin (TRPV1) (Transient Receptor Potential Vanilloid 1) receptor, a likely cause of the pain of post-herpetic neuralgia (PHN). This randomized placebo-controlled crossover study compares PHN pain one week before, for one week on the randomly assigned mannitol versus placebo cream and, after a three day washout, for one week on the other cream. Following this crossover study, participants receive mannitol cream for three months. Pain levels will be checked to assess whether continued use of this cream significantly reduces the pain levels associated with PHN. If pain persists beyond 3 months, participants will be offered mannitol and menthol cream for one month following which their pain levels will be checked.

NCT ID: NCT02484131 Completed - Breast Cancer Clinical Trials

Bone Health Management for Women Diagnosed With Breast Cancer

Start date: November 2015
Phase: N/A
Study type: Interventional

The purpose of this study is to test the feasibility of the study protocol. The study protocol was designed to evaluate questions - "Do educational materials improve dual x-ray absorptiometry (DXA) screening rates for women diagnosed with breast cancer" and "Does educational materials delivered by the participant's selected choice change DXA screening rates compared to the conventional mail method?".

NCT ID: NCT02484118 Completed - Clinical trials for End Stage Renal Failure on Dialysis

Hemodialysis Blood Flow and Urea Clearance

Start date: May 2015
Phase: N/A
Study type: Interventional

The study purpose is to determine whether two different hemodialysis blood flow rates each meet national dialysis standards for urea clearance. Urea is used as the primary marker of dialysis adequacy. It is an experimental study with a crossover design of minimum 38 participants. Participants will be selected from the accessible pool of end-stage renal disease clients at the Vancouver Community Dialysis Unit. The participants will dialyse at each pre-determined blood flow rate (320 mL/min and 380 mL/min) for two weeks each. Two forms of urea clearance data will be collected: one value that is routinely calculated by the dialysis machine and recorded on client treatment logs, and another that is calculated in a lab from blood samples.

NCT ID: NCT02483949 Completed - Clinical trials for Diabetes Mellitus Gestational Previous Pregnancy

Healthy Eating and Active Living for Diabetes - Gestational Diabetes Mellitus

HEALD-GDM
Start date: June 2015
Phase: N/A
Study type: Interventional

To examine the effectiveness of a group-based lifestyle modification program followed by peer-led telephone counselling for type 2 diabetes (T2D) and cardiovascular disease risk reduction. The lifestyle modification program will support daily ambulatory activity and low glycemic index food intake among women with previous gestational diabetes mellitus (GDM).

NCT ID: NCT02483637 Completed - Cryotherapy Effect Clinical Trials

Safety and Feasibility Study of Rejuvenairâ„¢ for Treating Chronic Bronchitis Patients

Feasibility
Start date: February 2016
Phase: N/A
Study type: Interventional

This study evaluates the safety of RejuvenAir Cryospray therapy to treat symptomatic chronic bronchitis patients with airflow restrictions.

NCT ID: NCT02483442 Completed - Pulmonary Embolism Clinical Trials

D-dimer Testing Tailored to Clinical Pretest Probability in Suspected Pulmonary Embolism

PEGeD
Start date: December 11, 2015
Phase:
Study type: Observational

Prospective, multicentre, cohort study assessing a diagnostic management strategy for suspected Pulmonary Embolism with independent central adjudication of outcomes

NCT ID: NCT02483351 Completed - Clinical trials for Subarachnoid Hemorrhage

Aneurysmal Subarachnoid Hemorrhage: Red Blood Cell Transfusion and Outcome

SAHaRA Pilot
Start date: October 2015
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of this study is to determine the feasibility of conducting a large trial examining the effect on clinical outcome of a liberal red blood cell (RBC) transfusion strategy compared to a restrictive strategy (usual care) in patients with aneurysmal subarachnoid hemorrhage (SAH).